BioVie Presents Overview Of Bezisterim Clinical Data On Longevity At 11th Aging Research And Drug Discovery Meeting
Author: Benzinga Newsdesk | August 13, 2024 08:21am
BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a poster presentation will be shared at the 11th Aging Research and Drug Discovery Meeting (ARDD 2024) being held August 26-30, 2024 in Copenhagen, Denmark.
Posted In: BIVI